Blog

Alzheimer’s disease is the leading neurological aging disorder impacting the lives of nearly 7 million Americans and 55 million individuals around the world. Alzheimer’s is the most common form of dementia, which is a general term for changes in cognitive abilities that interfere with daily life, such as memory loss. This disease is progressive, starting

Those of us who work in the Neurosciences are familiar with the variety of brain-related disorders that plague our society, often citing them to justify funding and support for our research programs. But on this Brain Health Day 2024, it is worth taking a moment to look closely at the status of brain health today

Imagine a mind caught in an endless loop of obsessions, anxiety, and ritualistic behaviors; welcome to the world of obsessive-compulsive disorder (OCD), a neuropsychiatric condition characterized by uncontrollable and recurring thoughts and repetitive behaviors. Research has linked OCD symptoms to hyperactivity in the striatum, a crucial brain region for motor control and decision-making. But how

Parkinson’s disease (PD) is a neurological disorder that affects 6 hundred thousand to more than 1 million people in the United States, or over 6 million worldwide, making it the second most prevalent brain disease behind Alzheimer’s. This disease presents differently in every individual but is typically marked by motor symptoms such as resting tremors,

From behavioral studies on learning and memory to sleep-wakefulness, 2023 was a year full of researchers uncovering interesting insights into the brain using Inscopix miniscopes. Did you know that the Inscopix community is illuminating the neurons responsible for REM sleep or performing experiments on contextual fear conditioning and discovering breakthroughs for diseases like Alzheimer’s? These

As a neuroscientist who leads a commercial organization, my mission and motivation come from seeing how our customers use Inscopix technology to address major questions in their labs. But each day, my team and I engage with Principal Investigators who are pressed by tightening budgets and must navigate a seemingly growing list of restrictions on